Aurobindo Pharma gets warning letter from USFDA for Andhra Pradesh unit

The drug firm, however, did not provide any details of the contents of the warning letter received from the regulator.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news